New Research on Applied Biotechnology

A special issue of Processes (ISSN 2227-9717). This special issue belongs to the section "Biological Processes and Systems".

Deadline for manuscript submissions: closed (20 July 2023)

Special Issue Editors

E-Mail Website
Guest Editor
Department of Marine Biology, Faculty of Marine Science and Technology, University of Hormozgan, Bandar Abbas, Iran
Interests: Enzyme Kinetics;Protein Purification;Biochemistry;Industrial Biotechnology

E-Mail Website
Guest Editor
1. Department of Bioengineering and IBB, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal 2. DREAMS and Faculty of Engineering, Universidade Lusófona de Humanidades e Tecnologias, Lisbon, Portugal
Interests: biocatalysis; bioreactors; bioprocess engineering
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Biotechnology is defined in the United Nations Convention on Biological Diversity as "any technology that uses biological systems, living organisms, and their derivatives to make or change products and processes with a specific application." The most important applied fields of biotechnology are bioprocess technologies, enzymes, waste, environmental, renewable resources, the production of transgenic plants and animals, health, pharmaceuticals, and food industries, and in the tree of biotechnology, the most important scientific fields underpinning biotechnology are physiology, plant and animal, cellular and molecular biology, immunology, microbiology, biochemistry and biophysics, genetics, and chemical engineering. There is no doubt that humanity is looking forward to the success of biotechnology in the future and knows that without it, it will not be possible to solve many problems and challenges. For this reason, most countries have made large investments in this field and are committed to the development of biotechnology.

This Special Issue on “New Research on Applied Biotechnology” seeks high-quality works focusing on the latest novel research in Applied Biotechnology. Topics include, but are not limited to:

  • Biotechnologically relevant enzymes and proteins;
  • Biochemical and bioprocess engineering;
  • Biofuel or bioproduct development;
  • Geneticist and genome engineering;
  • Biomedical engineering;
  • Bioenergy and biofuels;
  • Industrial microbiology.

Dr. Ahmad Homaei
Dr. Pedro Fernandes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • biotechnology
  • industrial application
  • commercialization
  • technology and innovation

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop